Item type |
琉球大学リポジトリ登録用アイテムタイプ(1) |
公開日 |
2023-07-18 |
タイトル |
|
|
タイトル |
Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics |
|
言語 |
en |
作成者 |
Aoki, Yumi
Takaesu, Yoshikazu
Suzuki, Masahiro
Okajima, Isa
Takeshima, Masahiro
Shimura, Akiyoshi
Utsumi, Tomohiro
Kotorii, Nozomu
Yamashita, Hidehisa
Kuriyama, Kenichi
Watanabe, Norio
Mishima, Kazuo
|
アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
権利情報 |
|
|
言語 |
en |
|
権利情報 |
© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology. |
権利情報 |
|
|
言語 |
en |
|
権利情報Resource |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
|
権利情報 |
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial- NoDerivs License |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
benzodiazepines |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
chronic insomnia |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
decision aid, hypnotics |
主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
shared decision-making |
内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Aim: To describe the development and acceptability of a decision aid (DA) for chronic insomnia considering discontinuation of benzodiazepine (BZD) and benzodiazepine receptor agonist (BZRA) hypnotics, and if discontinuing, tapering with or without cognitive behavioral therapy for insomnia (CBT-I). Methods: We reviewed relevant literature describing chronic insomnia to identify options. We used the results of the systematic review and meta-analysis conducted previously to determine the related outcomes of two options: discontinuation of BZD/BZRA hypnotics by gradual tapering alone and discontinuation of BZD/BZRA hypnotics by gradual tapering with CBT-I. We then developed a prototype of DA following the International Patient Decision Aid Standards. A mixed methods survey was conducted to assess the acceptability among patients and healthcare providers. Results: The prototype consisted of a description of insomnia, options of continuing or discontinuing BZD/BRZA hypnotics (if discontinuing, the options of tapering hypnotics with or without CBT-I), pros and cons of each option, and a value clarification |
|
言語 |
en |
出版者 |
|
|
言語 |
en |
|
出版者 |
© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology. |
言語 |
|
|
言語 |
eng |
資源タイプ |
|
|
資源タイプ |
journal article |
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
関連情報 |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1002/npr2.12219 |
収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2574-173X |
収録物名 |
|
|
言語 |
en |
|
収録物名 |
Neuropsychopharmacology Reports |
書誌情報 |
巻 42,
号 1,
p. 10-20,
発行日 2021-11-22
|